Goldman Sachs Group Inc Dynavax Technologies Corp Put Options Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$10.05 - $11.61 $469,335 - $542,187
46,700 New
46,700 $520,000
Q1 2024

May 15, 2024
BUY
$11.7 - $14.98 $235,170 - $301,098
20,100 New
20,100 $249,000
Q3 2021

Nov 10, 2021
BUY
$9.16 - $19.83 $283,044 - $612,747
30,900 New
30,900 $594,000

Others Institutions Holding DVAX

# of Institutions
274
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.57B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email